proxodolol has been researched along with Malignant Hypertension in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdrakhnanov, VR; Filippov, DV; Gaponova, NI; Plavunov, NF | 1 |
1 other study(ies) available for proxodolol and Malignant Hypertension
Article | Year |
---|---|
[Possibilities of the use of parenteral form of α- and β-adrenoblocker for the treatment of hypertensive crises at prehospital stage].
Topics: Acute Coronary Syndrome; Acute Disease; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Blood Pressure; Drug Repositioning; Emergency Medical Services; Female; Heart Rate; Humans; Hypertension, Malignant; Hypertensive Encephalopathy; Injections, Intravenous; Male; Middle Aged; Oxadiazoles; Therapies, Investigational | 2010 |